pharma · Opioid Use Disorder · Opioid Dependence
Indivior Pty
Indivior Pty Ltd
Indivior is a pharma organization headquartered in Richmond, USA. Primary therapeutic focus areas include Opioid Use Disorder, Opioid Dependence, Schizophrenia, Opioid Dependency, Opiate Dependence. NovaPharmaNews links
., Richmond, VA, US HQ
967 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- ., Richmond, VA, US
- Employees
- 967
- Programs
- 39
- Drugs
- 19
- Patents
- 34
RBP-6000
Phase 3 · small molecule · Opioid Use Disorder
RBP-6000 for Opioid Use Disorder is a Phase 3 program (small_molecule) at Indivior Pty Ltd with 4 ClinicalTrials.gov record(s).
Internal code RB-US-10-0011
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Indivior Pty Ltd
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Opioid Use Disorder
- Status
- completed
- Trials
- 4